Ophthalmology · Birmingham, AL
NPI
1386847374
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 19th St S
Birmingham, AL, 35205
Phone (205) 427-4348
Groups this clinician bills Medicare through
Medicare paid, 2024
$214K
2,240 services
Medicare patients, 2024
1,013
Average age 75
Drug cost, 2024
$1.9M
3,334 prescriptions
Company payments, 2025
$23K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristin C Bains was code 92014 (ophthalmological e&m), 570 times for 544 patients. In total Kristin C Bains billed 2,240 services in 43 codes, and Medicare paid $214K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 570 | 544 | $73.94 | $42K |
| 99213 Office E&M - Established | Office | 386 | 298 | $52.62 | $20K |
| 99214 Office E&M - Established | Office | 301 | 232 | $77.37 | $23K |
| 92134 Computerized Ophthalmic Imaging | Office | 158 | 135 | $23.87 | $3,772 |
| 92136 Ultrasound - Nonspecific | Office | 146 | 102 | $26.37 | $3,850 |
| 99204 Office E&M - New | Office | 129 | 129 | $100.56 | $13K |
| 66984 Cataract Surgery | Facility | 108 | 69 | $342.78 | $37K |
| 92025 Test - Miscellaneous | Office | 74 | 67 | $21.03 | $1,556 |
| 66821 Cataract Surgery | Facility | 49 | 42 | $209.54 | $10K |
| 92133 Computerized Ophthalmic Imaging | Office | 44 | 42 | $22.00 | $968 |
| 68761 Eye | Office | 34 | 29 | $118.33 | $4,023 |
| 92083 Vision, Hearing, and Speech Services | Office | 33 | 33 | $33.64 | $1,110 |
| 65756 Eye | Facility | 31 | 26 | $817.44 | $25K |
| 92004 Ophthalmological E&M | Office | 26 | 26 | $88.97 | $2,313 |
| 67820 Eye | Office | 24 | 15 | $13.14 | $315 |
By year: 2022 $225K for 2,146 services; 2023 $240K for 2,407 services; 2024 $214K for 2,240 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristin C Bains prescribed most often to Medicare patients was Prednisolone Acetate, with 668 prescriptions and refills. In total Kristin C Bains wrote 3,334 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 668 | 1,233 | 287 | $35K |
| Fluorometholone Generic | 481 | 902 | 143 | $38K |
| Restasis Cyclosporine | 275 | 473 | 125 | $277K |
| Latanoprost Generic | 256 | 524 | 78 | $4,428 |
| Valacyclovir Valacyclovir Hcl | 228 | 449 | 59 | $9,525 |
| Moxifloxacin Moxifloxacin Hcl | 226 | 229 | 148 | $7,118 |
| Cyclosporine Generic | 196 | 381 | 87 | $129K |
| Azelastine Hcl Generic | 118 | 154 | 45 | $3,582 |
| Xiidra Lifitegrast | 118 | 193 | 39 | $130K |
| Timolol Maleate Generic | 103 | 211 | 37 | $943 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 81 | 186 | 33 | $1,944 |
| Loteprednol Etabonate Generic | 67 | 105 | 20 | $11K |
| Doxycycline Hyclate Generic | 64 | 104 | 17 | $2,215 |
| Tyrvaya Varenicline Tartrate | 52 | 52 | 16 | $34K |
| Acyclovir Generic | 49 | 89 | Under 11 | $948 |
Brand drugs: 1,817 claims; generic drugs: 1,517 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristin C Bains $23K ($23K in general payments such as food, travel and fees) from 9 companies. The largest payer was Glaukos Corporation with $14K.
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation GKOS | 34 | $14K |
| Dompe US, Inc. | 13 | $7,340 |
| Alcon Vision LLC ALC | 13 | $807 |
| Harrow Eye, LLC | 10 | $236 |
| Bausch & Lomb Americas Inc. BLCO | 8 | $228 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $121 |
| Oyster Point Pharma, Inc. | 3 | $62.57 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $23.87 |
| Amgen Inc. AMGN | 1 | $16.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.